PFO
VKTX icon

Pathstone Family Office’s Viking Therapeutics VKTX Stock Holding History

Pathstone Family Office’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,915
Closed -$232K – 1306
2023
Q1 		$232K Buy
+13,915
New +$232K ﹤0.01% 1025